Recursion Pharmaceuticals, Inc. (RXRX)

4.85 +0.16 (+3.41%) USD  |  NASDAQ  |  Jan 14, 16:00
4.80 -0.05 (-1.03%) After-Hours: 20:00
More

Recursion Pharmaceuticals Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for RXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Hims & Hers Health, Inc. Upgrade
XOMA Royalty Corp. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade